Travere’s stock price climbed by 14% following the announcement it will seek an ...
EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under th...
Health Canada has approved MSD's Keytruda for treating adults with resectable st...
Trump's tariffs will not only impact sponsors, but higher costs will ripple down...
China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of St...
Tim Andrews underwent the procedure with the pig kidney as part of a three-perso...
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in ...
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desm...
AbbVie has received US FDA approval for Emblaveo to be used in conjunction with ...
Given the number of comorbidities associated with obesity, the market's growth w...
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreem...
Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster...
A study led by UCL found that individuals with rare diseases were five times mor...
With Dry January firmly behind us, many adults are prompted to reassess their re...
Relmada has acquired complete ownership rights to Sepranolone, developed for Tou...
